Q1 results, Rs 0.80 interim dividend, new MD after ex-MD demise
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.3 pts less than Nifty Microcap 250 and 2.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved Q1FY27 results: revenue from operations 24.67 cr (up 4.7 percent YoY), PAT 2.31 cr (down 18.7 percent YoY), EPS Rs 1.76. Declared Rs 0.80 per share interim dividend, record date Aug 21, payment by Sep 13. Mr. Mahendra Turakhia, ex-MD, passed away on Aug 2. Mr. Kishor Turakhia elevated from whole-time director to MD for 5 years. Mrs. Chandan Turakhia (wife of late MD) appointed as additional non-executive director.
Modest revenue growth but profit declined nearly 19 percent. Rs 0.80 dividend is positive for shareholders. Key leadership transition following ex-MD demise may raise near-term concerns.